2006
DOI: 10.1084/jem.20052267
|View full text |Cite
|
Sign up to set email alerts
|

Carbon monoxide reverses established pulmonary hypertension

Abstract: Pulmonary arterial hypertension (PAH) is an incurable disease characterized by a progressive increase in pulmonary vascular resistance leading to right heart failure. Carbon monoxide (CO) has emerged as a potently protective, homeostatic molecule that prevents the development of vascular disorders when administered prophylactically. The data presented in this paper demonstrate that CO can also act as a therapeutic (i.e., where exposure to CO is initiated after pathology is established). In three rodent models … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
130
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 150 publications
(132 citation statements)
references
References 33 publications
2
130
0
Order By: Relevance
“…Therefore, in contrast to other studies showing the antiapoptotic effects of CO, Fas/CD95-induced cell death in Jurkat T cells is augmented by exposure to CO partially occurring via inhibition in the activation of the extracellular signal-regulated kinase (ERK) MAPK [154]. Furthermore, CO has been demonstrated to reverse established pulmonary arterial hypertension in vivo, an incurable disease characterized by a progressive increase in pulmonary vascular resistance, leading to heart failure [134]. This occurs in part suppressing growth and increasing apoptosis of the smooth muscle cells of the pulmonary artery.…”
Section: Co Signalingmentioning
confidence: 57%
See 2 more Smart Citations
“…Therefore, in contrast to other studies showing the antiapoptotic effects of CO, Fas/CD95-induced cell death in Jurkat T cells is augmented by exposure to CO partially occurring via inhibition in the activation of the extracellular signal-regulated kinase (ERK) MAPK [154]. Furthermore, CO has been demonstrated to reverse established pulmonary arterial hypertension in vivo, an incurable disease characterized by a progressive increase in pulmonary vascular resistance, leading to heart failure [134]. This occurs in part suppressing growth and increasing apoptosis of the smooth muscle cells of the pulmonary artery.…”
Section: Co Signalingmentioning
confidence: 57%
“…The ability of CO to exert its remodeling effects requires the expression and function of eNOS/NOS3. Indeed, NO acts in part as the effector molecule to induce cell death of pulmonary artery smooth muscle cells while preserving the endothelial cells [134] (Fig. 2).…”
Section: Co Signalingmentioning
confidence: 99%
See 1 more Smart Citation
“…Low concentration CO can reverse established pulmonary hypertension in rats, induced by chronic hypoxia or monocrotaline administration (109). Observations of COmediated tissue protection have also been described in transplantation of heart, lung, kidney, liver, and intestinal allografts or xenografts, whereby application of CO to the recipient or to the graft reduced inflammation and apoptosis associated with I/ R injury, thus reducing the probability of graft rejection (12,(110)(111)(112)(113)(114).…”
Section: Co and Bv/br: Tissue Protection In Preclinical Modelsmentioning
confidence: 99%
“…Primary rat and mouse pulmonary artery smooth muscle cells (PASMCs) were isolated as previously described 41 and cultured in DMEM (low glucose):F12 medium (1:1 vol/vol) with 10% FBS, 2 mmol/L L-glutamine, 100 U/mL penicillin, and 100 g/mL streptomycin in a 37°C, 5% CO 2 incubator. PASMCs from passages 3 through 7 only were used.…”
Section: Cell Culturementioning
confidence: 99%